Viewing Study NCT00051740



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00051740
Status: COMPLETED
Last Update Posted: 2013-04-09
First Post: 2003-01-15

Brief Title: Treating Thought Problems in Patients With Schizophrenia
Sponsor: The University of Texas Health Science Center at San Antonio
Organization: The University of Texas Health Science Center at San Antonio

Study Overview

Official Title: Compensating for Cognitive Deficits in Schizophrenia
Status: COMPLETED
Status Verified Date: 2013-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will compare Cognitive Adaptation Training CAT to minimal schizophrenia treatment This study will also determine whether the intensity of CAT can be reduced and still provide benefits to patients with schizophrenia
Detailed Description: Many schizophrenia patients have serious difficulties that affect their quality of life Cognitive Adaptation Training CAT may improve adaptive functioning quality of life and rates of relapse in schizophrenia patients CAT which involves compensatory strategies or environmental supports is tailored to each individual and is based on executive functioning levels and other factors

Participants are randomly assigned to CAT Minimal Environmental Supports MES or treatment as usual for 2 years Participants receiving CAT will have a trained therapist make weekly visits to their home for 9 months Over the following 3 months the frequency of CAT visits will be slowly reduced to once a month For the remaining 12 months of treatment patients receive CAT only once a month

Participants assigned to the MES group receive a generic set of supplies and equipment calendar alarm clock watch bus passes etc at the beginning of the 2-year period Each month the supplies are replenished as necessary during the patients scheduled clinic visit

In all groups assessments of adaptive function and quality of life occur at study start and at 3 6 9 18 and 24 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
DATR A4-GPS None None None